 |
Human monoclonal antibody directed against human Activin A |
|---|---|
| Trade Name | |
| Orphan Indication | Fibrodysplasia ossificans progressiva |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-19 00:00:00 |
| Sponsor | Regeneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591 |
